Today's retinopathy evidence points to something an ophthalmologist can do without prescribing anything: use the clinic letter. When you see a patient with progressing diabetic retinopathy, note in the reply to their physician that glucose-lowering choice may matter to the eye — an SGLT2 inhibitor is associated with slower progression than a sulfonylurea. It costs a sentence, reaches the person who actually controls the regimen, and turns a screening finding into a systemic action rather than another appointment.
- Name the systemic implication of retinopathy in the letter back to the physician
- Flag that SGLT2 inhibitors are linked to slower progression than sulfonylureas
- Close the loop between eye screening and diabetes management
- One sentence to the prescriber does more than another eye review
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for ophthalmology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free